Friday May 7, 2021 

ACCREDITED SYMPOSIUM 

The New Frontier: Worsening Heart Failure as a Target for Therapy (Bayer)
Justin Ezekowitz, MD (Chair); Anique Ducharme, MD; Jonathan Howlett, MD   

PLENARY SESSION #1: A NEW ERA FOR HEART FAILURE

New HF Guidelines for a New Era
Michael McDonald, MD

Treating HFrEF: What Comes After the Big Four?
Nadia Giannetti, MD

In-Hospital HF Management
Lisa Mielniczuk, MD 

Something in the Air: Environmental Effects Upon the Failing Heart
Deepak Bhatt, MD 

CORRIDOR CONSULTS (UNACCREDITED)  

Debate: Which Should be Started First, ARNI or SGLT2i? (Bi-Lilly) 
Jacob A. Udell, MD; Abhinav Sharma, MD; Shelley Zieroth, MD  

Overview of the 2021 CANM Cardiac Amyloid PYP Imaging Guidelines (Pfizer) 
Margot Davis, MD; Jean-Luc C. Urbain, MD  

What to Consider When Referring for Genetic Testing? (Akcea) 
Nowell M. Fine, MD; Nathalie Bolduc  

WORKSHOPS

POCUS in HF: Back by Popular Demand
Ryan Davey, MD; Sharon Mulvagh, MD

Guide to Drug Withdrawal in HFrecEF 
Abhinav Sharma, MD 

Identifying Frailty in HF and Why it Matters 
Jonathan Afilalo, MD  

Optimizing HF and Device Therapy After Cardiac Device Implantation 
Kiran Sidhu, MD 

UNACCREDITED SYMPOSIA 

#Heart Success - What Can Canadians do to Fight Heart Failure?  (Novartis)
Shelley Zieroth, MD; Katie Connolly, MD; James Januzzi, MD, Stephanie Poon, MD; Sean Virani, MD  

Hiding in Plain Sight: Autonomic Neuropathy in Heart Failure Patients with hAATR (Alnylam) 
Nowell Fine, MD; Anil Gupta, MD; Anique Ducharme, MD; Zaeem Siddiqi, MD  

PLENARY SESSION #2: CHFS & JACC: HF Joint Plenary
NOVEL CONCEPTS IN HEART FAILURE THERAPY

JACC HF: Great HF Papers of the Past Year
Christopher O’Connor, MD (JACC: HF)

Control of Atrial Rate and Rhythm in 2021
Jason Andrade, MD

Current and Future Role of Artificial Intelligence in the Diagnosis of HF 
Carolyn Lam, MD

Special Imaging for Special Cardiomyopathies 
Robert Beanlands, MD

CORRIDOR CONSULTS (UNACCREDITED) 

Clinical Applications of the 2021 CANM Cardiac Amyloid PYP Imaging Guidelines (Pfizer)
Nowell M. Fine MD; Cigdem Akincioglu, MD  

Saturday May 8, 2021

PLENARY SESSION #3: CHFS & HFA of ESC Joint Plenary
TREATMENT FOR ALL EJECTION FRACTIONS

Five Things to Know About Diagnosis of HFpEF
Gianluigi Savarese, MD (HFA) 

Five Things to Know About Treatment of HFpEF
Scott Solomon, MD  

Is It Prime Time for IV Iron? 
Eileen O’Meara, MD 

Emerging Alternatives for Decongesting HF 
Petar Seferovic, MD (HFA) 

ACUTE HF TRACK  

Treatment of the Diuretic Resistant Patient with Acute HF 
Stephanie Poon, MD  

Dyspnea NYD: Pulmonary or Cardiac and What to do Next 
Michael Heffernan, MD 

Which Elderly Patients Can Be Considered for Inotropic Therapy 
Phyllis Billia, MD  

Should We Integrate New HF Drugs During In-Hospital Care? 
Anil Gupta, MD  

CORRIDOR CONSULTS (UNACCREDITED) 

Does my Patient Have Worsening Heart Failure? Can it be Treated? (Bayer) 
Justin A. Ezekowitz; Anil Gupta, MD  

What can Ottawa and Alberta Agree On? Approaches to Drug Initiation in HFrEF (Novartis) 
Jonathan Howlett, MD; Lisa Mielniczuk, MD  

Is Titrating too Complex? Focusing on Optimized Results for Patients (AstraZeneca) with HFrEF 
Robert McKelvie, MD 

WORKSHOPS

A Shared Decision-Making Approach to Goals of Care 
Caroline McGuinty, MD   

Practical Approach to HF Medication 
Rodolfo Pike, NP; Nadia Thomson, NP   

Virtual HF Monitoring 
Patrice Lindsay, RN, PhD (Heart & Stroke); Mary O'Sullivan, RN  

L'échocardiograpie chez l'insuffisant cardiaque: paramètres au-delà de la FEVG 
Catherine Bourque, MD   

ACCREDITED SYMPOSIUM   

Launching the Moonshot for Heart Failure: Travelling Towards the Totality of Evidence Together (BI-Lilly)
Shelley Zieroth, MD (Chair); Javed Butler, MD; Jackie Ratz (HeartLife)  

PLENARY SESSION #4:CHFS & HFSA Joint Plenary
HEART FAILURE IN MULTISYSTEM DISEASE 

Next Door Neighbor: The Liver in HF 
Stacey Prenner, MD (HFSA)   

Cardiodiabetes in 2021 
Subodh Verma, MD  

Percutaneous Treatment of AV Valve Regurgitation 
Neil Fam, MD  

Cancer as a Precursor to HF 
Ronald Witteles, MD (HFSA)  

CORRIDOR CONSULTS (UNACCREDITED)

Do You Know What Quality of Life Means for Your Patients with Heart Failure? (Bi-Lilly) 
Jonathan Howlett, MD  

Screening Tool to Help Recognize Amyloidosis (Alnylam)
Nowell M. Fine MD  

Synergistic Role of Beta-Blockers and Ivabradine (Servier) 
Serge Lepage, MD  

WORKSHOPS 

Effects of Non-CV Drugs on the Heart 
Ricky Turgeon, PharmD  

How to Involve QA In Hospital HF Care 
Robert McKelvie, MD   

CCS/CHFS Heart Failure Guidelines - Evidence to Support Innovation in Practice 
Sean Virani, MD   

Lignes directrices de la SCC et de la SCIC sur l’insuffisance cardiaque- Preuves soutenant l’innovation dans la pratique 
Eileen O'Meara, MD   

What Has ISCHEMIA Taught Us About Coronary Revascularization for HFrEF 
Robert Miller, MD